THE WEAPONIZATION OF NANOTECHNOLOGY AND INDUCEMENT OF HEART DISEASE

This is the basic weaponization principle of nanoparticles now found in virtually every consumer product.

When excited, cavitated (imploded) and inhaled, these 30nm particulates, virtually undectectable, alter cardiac chemistry and constrict coronary arteries and induce atrial fibrilation.

They remain inert until activated by satellite based microwave satellites which also conduct unlimited surveillance.

They were first proposed by Richard Fenyman in 1964 and developed by DARPA and the NSC in response to the disorders of the 1960's and 70's. In addition, they can neutralize any potential leaders or "troublemakers" who might oppose governemnt policies.

Nano-Vehicle acts as cluster bomb for tumors
September 18, 2010 Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity, and a battered immune system. Now, a new way to deliver this life-saving therapy to cancer patients -- getting it straight to the source of the disease -- has been developed by Dan Peer and Rimona Margalit and their colleagues at Tel Aviv University. Drs. Peer and Margalit have developed a nano-sized vehicle with the ability to deliver chemotherapy drugs directly into cancer cells while avoiding interaction with healthy cells, increasing the efficiency of chemotherapeutic treatment while reducing its side effects.




THIS IS THE FLIP SIDE OF THE COIN!

www.CuringProstateCancer.com



"The vehicle is very similar to a cluster bomb," explains Dr. Peer. Inside the nano-vehicle itself are nanoparticles loaded with chemotherapy drugs. When the delivery vehicle, comprising multiple nanoparticles, comes into contact with cancer cells, it releases the chemotherapeutic payload directly into the cell. According to Dr. Peer, the nanoparticle device can be used to treat many different types of cancer, including lung, blood, colon, breast, ovarian, pancreatic, and even several types of brain cancers. A paper describing their new nanoparticles and their use in targeting tumors appears in the journal Biomaterials.

The key to the drug delivery platform is hyaluronan, the molecule used to create the outer coating of this clustered nanoparticle. Hyaluronan is a sugar recognized by receptors on many types of cancer cells. "When the nano-vehicle interacts with the receptor on the cancerous cell, the receptor undergoes a structural change and the chemotherapy payload is released directly into the cancer cell," says Dr. Peer. The result, he explains, is a more to more focused chemotherapeutic treatment against the diseased cells.